A Pharmacokinetic and Pharmacodynamic Study of Omecamtiv Mecarbil in Healthy Volunteers

Status:
Completed

Trial end date:
2006-04-01

Target enrollment:

Participant gender:

This study will assess the safety, tolerability, and pharmacodynamics of omecamtiv mecarbil infusion in healthy male volunteers.

Phase 1

Cytokinetics